Resverlogix Corp.

News & Events

Press Releases

In The Media

1. Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024

   Newsfile SEP 3, 2024 10:15 AM EDT
   Numerous GLP-1 RA and SGLT2i presentations touted their clinical results, providing continued exc...
   READ ARTICLE

2. Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension

   Newsfile JUL 31, 2024 6:30 PM EDT
   Calgary, Alberta--(Newsfile Corp. - July 31, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix",...
   READ ARTICLE

3. Resverlogix Provides Update Regarding Two-Year Extension of Debenture and Elimination of Conversion Privileges

   Newsfile JUL 16, 2024 7:15 AM EDT
   Calgary, Alberta--(Newsfile Corp. - July 16, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlo...
   READ ARTICLE

4. Resverlogix Announces Updated Annual and Special Meeting of Shareholders

   Newsfile MAY 28, 2024 5:00 PM EDT
   Calgary, Alberta--(Newsfile Corp. - May 28, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" o...
   READ ARTICLE

5. Resverlogix Announces Two-Year Extension of Debenture and Elimination of Conversion Privileges

   Newsfile MAY 13, 2024 5:00 PM EDT
   Calgary, Alberta--(Newsfile Corp. - May 13, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" o...
   READ ARTICLE

6. Resverlogix Announces Change to Its Board of Directors

   Newsfile FEB 21, 2024 7:00 PM EST
   Calgary, Alberta--(Newsfile Corp. - February 21, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlog...
   READ ARTICLE

7. Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits

   Newsfile JAN 11, 2024 7:15 AM EST
   Calgary, Alberta--(Newsfile Corp. - January 11, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogi...
   READ ARTICLE

8. Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

   Newsfile OCT 4, 2023 7:12 AM EDT
   Calgary, Alberta--(Newsfile Corp. - October 4, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix...
   READ ARTICLE

9. Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes

   Newsfile AUG 29, 2023 7:15 AM EDT
   Amsterdam, Netherlands and Calgary, Alberta--(Newsfile Corp. - August 29, 2023) - Resverlogix Cor...
   READ ARTICLE

10. Resverlogix Announces Warrant Repricing and One-Year Extension

    Newsfile JUN 29, 2023 6:00 PM EDT
    Calgary, Alberta--(Newsfile Corp. - June 29, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" ...
    READ ARTICLE